dr. weber on emerging immunotherapy combinations in melanoma
Published 4 years ago • 209 plays • Length 1:16Download video MP4
Download video MP3
Similar videos
-
1:03
dr. weber on risk and benefits with immunotherapy combos in melanoma
-
0:49
dr. weber on emerging therapies in melanoma
-
6:56
emerging immunotherapy combinations for melanoma
-
2:25
dr. weber on discontinuing immunotherapy in melanoma
-
2:05
dr. weber on adjuvant approaches in stage iii melanoma
-
1:22
dr. weber on adjuvant pembrolizumab in melanoma
-
5:05
emerging combination regimens in advanced melanoma
-
1:46
dr. weber on selecting immunotherapy for patients with melanoma
-
1:05
dr. weber on the future of checkpoint inhibitors in melanoma
-
4:25
the phenomenon of immunotherapy in melanoma
-
1:36
dr. weber on combination strategies for braf-mutant melanoma
-
0:57
dr. weber on fda approval of pembrolizumab for stage iii melanoma
-
1:58
dr. weber on duration of checkpoint inhibitor therapy in melanoma
-
7:00
metastatic melanoma: the immunotherapy approach
-
1:44
dr. jeffrey weber on optimal therapy sequences in advanced melanoma
-
1:14
dr. weber discusses advancements in melanoma
-
1:50
dr. weber on research efforts examining neoadjuvant approaches in melanoma
-
1:05
dr. weber on rationale for the checkmate-238 trial in melanoma
-
1:06
dr. luke on the future role of immunotherapy combinations in melanoma